Revvity stock rises 7.36% and outperforms competitors
Updated
Updated · MarketWatch · May 6
Revvity stock rises 7.36% and outperforms competitors
6 articles · Updated · MarketWatch · May 6
The shares closed at $99.09 on Wednesday, marking a second straight gain, while trading volume jumped to 3.0 million from a 50-day average of 1.1 million.
Revvity beat peers including Danaher, up 0.17%, IDEXX Laboratories, up 2.89%, and Agilent Technologies, up 0.14%, during a broadly positive US market session.
The S&P 500 rose 1.46% and the Dow gained 1.24%, but Revvity still finished 16.24% below its 52-week high of $118.30 reached on 22 January.
Revvity beat Q1 estimates but cut its 2026 forecast. Why is Wall Street cheering a company that just lowered expectations?
As competitors make bold moves, is Revvity's sudden surge a sign of underlying strength or a temporary market illusion?